SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus

Despite recent advances in the research on oncolytic viruses (OVs), a better understanding of how to enhance their replication is key to improving their therapeutic index. Understanding viral replication is important to improve treatment outcomes based on enhanced viral spreading within the tumor mi...

Full description

Bibliographic Details

Main Authors:	Alkayyal, Almohanad A., Ajina, Reham, Cacciabue, Marco Polo Domingo, Alkayyal, Aaesha A., Saeedi, Nizar H., Hussain Alshehry, Taofik, Kaboha, Feras, Alotaibi, Mohammed A., Zaidan, Nada, Shah, Khalid, Alroqi, Fayhan, Bakur Mahmoud, Ahmad
Format:	Artículo
Language:	Inglés
Published:	Frontiers Media 2023
Subjects:	Severe Acute Respiratory Syndrome Coronavirus 2 Oncology Melanoma Vesicular Stomatitis Virus Coronavirus del Síndrome Respiratorio Agudo Arave 2 Oncología Virus de la Estomatitis Vesicular SARS-CoV-2 Viroterapia Agente Anticancerígeno Virotherapy Anticancer Agent
Online Access:	http://hdl.handle.net/20.500.12123/15220 https://www.frontiersin.org/articles/10.3389/fimmu.2023.1082191/full https://doi.org/10.3389/fimmu.2023.1082191